DOJ Continues to Discuss Updates to Compliance Program Guidance and Corporate Enforcement Policies

Sheppard Mullin – At the Food and Drug Law Institute’s Annual Conference in May, the DOJ’s Consumer Protection Branch and the FDA discussed each agency’s approach to the CPB’s new Voluntary Self-Disclosure Policy for Business Organizations.